GENE ONLINE|News &
Opinion
Blog

China
China biotech industry
China’s Biotech Industry Is Having Its Moonshot Moment
2025-04-14
R&D Myasthenia Gravis
Chinese Researchers Decode Autoimmune Mechanisms of Myasthenia Gravis
2025-04-11
Editors' Picks IlluminaTrade War
China Blocks Illumina’s Sequencers as U.S. Tariffs Double–Trade War Fallout Intensifies
2025-03-06
Asia Pacific Trade War
China’s Biopharma Power Play: Shaking Up Global Drug Markets Amid Trump’s Transatlantic Trade Wars
2025-02-17
Deals Weight Loss Drugsmuscle-preserving
China’s Laekna Joins Forces with Weight-Loss Giant Lilly on Muscle-Preserving Obesity Drug in Expanding $150B Market
2024-11-21
Asia-Pacific APACIndustry
APAC Leading the Industry in Adoptive Cell Therapy – Trials, Economic Growth, and Pioneering Companies
2024-06-24
Deals ADC TherapeuticsADCdealsChina
ArriVent and Alphamab Partner in $615.5 Million Collaboration for Novel ADC Cancer Treatments
2024-06-06Partner
MediLink and BioNTech Sign $1.8 Billion ADC Deal to Expand Cancer Therapy Innovations
2024-06-06
China APACChinaInsulinDiabetesStem Cell Therapy
Breakthrough Cell Transplant Frees Chinese Patient from Insulin Dependency
2024-06-05
China sedentary behavior
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Special ChinaGlobal Events
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
China Wuxi AppTecBIOChina
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
IPO IPO
Chinese Biotechs Seeks IPO Growth on US Shores
2024-03-13
Partner
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
2023-12-24
Partner
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
2023-12-17
1 2 3 … 8
LATEST
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
READ MORE
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top